Niemann–Pick type C: focus on the adolescent/adult onset form
- 29 March 2016
- journal article
- other
- Published by Taylor & Francis in International Journal of Neuroscience
- Vol. 126 (11) , 963-971
Abstract
Niemann-Pick disease type C (NP-C) is an inherited sphingolipidosis characterized by progressive neurological deterioration and early mortality. The symptomatology and disease progression of NP-C are markedly affected by the age at onset of neurological manifestations, and categorization into early-infantile, late-infantile, juvenile, adolescent/adult neurological onset forms can aid evaluation of disease course and responses to therapy. Here, we review current information on the detection, diagnosis, monitoring and treatment of NP-C, with a focus on the adolescent/adult-onset form. A recent analysis indicated that the combined incidence of NPC related to NPC1 gene mutations (‘NPC1’) and NP-C related to NPC2 gene mutations (‘NPC2’) is approximately 1 case in every 89.000 live births. In particular, late-onset phenotypes might well provide a greater contribution to the overall incidence than has previously been reported. Some neuropathological features in NP-C are held in common with other advanced-age onset diseases such as Alzheimer's disease. Visceral symptoms such as splenomegaly are frequently asymptomatic in patients with adolescent/adult-onset NP-C, and are only occasionally detected during routine ultrasound assessments. In contrast, most patients with adolescent/adult-onset exhibit some degree of slowly-progressive, non disease-specific movement disorders (e.g., cerebellar ataxia), and/or more pathognomonic neurological signs such as vertical supranuclear gaze palsy (VSGP). An increasing number of adolescent/adult-onset cases have been reported following initial recognition of cognitive impairment and/or psychiatric signs. The recent development and implementation of new clinical screening tools (e.g. the NP-C suspicion index), and biomarkers (e.g., plasma oxysterols), should help identify patients who warrant further investigation and possible treatment.Keywords
This publication has 88 references indexed in Scilit:
- Genetic screening for Niemann-Pick disease type C in adults with neurological and psychiatric symptoms: findings from the ZOOM studyHuman Molecular Genetics, 2013
- Disease and patient characteristics in NP-C patients: findings from an international disease registryOrphanet Journal of Rare Diseases, 2013
- Normalization of Cholesterol Homeostasis by 2-Hydroxypropyl-β-cyclodextrin in Neurons and Glia from Niemann-Pick C1 (NPC1)-deficient MiceJournal of Biological Chemistry, 2012
- Dysphagia as a risk factor for mortality in Niemann-Pick disease type C: systematic literature review and evidence from studies with miglustatOrphanet Journal of Rare Diseases, 2012
- A sensitive and specific LC-MS/MS method for rapid diagnosis of Niemann-Pick C1 disease from human plasmaJournal of Lipid Research, 2011
- Histone deacetylase inhibitor treatment dramatically reduces cholesterol accumulation in Niemann-Pick type C1 mutant human fibroblastsProceedings of the National Academy of Sciences, 2011
- Cholesterol Oxidation Products Are Sensitive and Specific Blood-Based Biomarkers for Niemann-Pick C1 DiseaseScience Translational Medicine, 2010
- Niemann-Pick disease type COrphanet Journal of Rare Diseases, 2010
- Structure of N-Terminal Domain of NPC1 Reveals Distinct Subdomains for Binding and Transfer of CholesterolCell, 2009
- Niemann-Pick type C disease in a 68-year-old patientJournal of Neurology, Neurosurgery & Psychiatry, 2006